Treatment of Drug-Resistant Tuberculosis
Published: November 2019
$9.95
Print Copy Information:
- 16 pages
- Spiral Bound
- 80# Aqueous Coating
- 4.25" x 7.25"
- Ships in 5 – 10 business days
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
- Key Points
- Summary of Good Practices
- Treatment Recommendations
- For the selection of an effective MDR-TB treatment regimen and duration of MDR-TB treatment
- For the selection of oral drugs for MDR-TB treatment
- For selected oral drugs previously included in regimens for the treatment of MDR-TB
- For the selection of drugs administered through injection when needed to compose an effective treatment regimen for MDR-TB
- For the use of the WHO-recommended standardized shorter-course 9–12 month regimen for MDR-TB
- For the role of surgery in the treatment of MDR-TB
- For the treatment of isoniazid-resistant TB
- For the management of contacts to patients with MDR-TB
- Tables
- Summary of Recommendations on Drugs for Use in a Treatment Regimen for Patients with MDR-TB, Including Strength of Recommendation, Certainty in the Evidence and Relative Effects on Death and Treatment Success
- Clinical Strategy to Build an Individualized Treatment Regimen for MDR-TB
- Doses of Drugs for Treatment of Adults and Children with MDR-TB
- Select Antiretroviral and Non–rifamycin-based Anti-tuberculosis Drug Overlapping Toxicities and Potential Adverse Drug-drug Interactions
- For purchases under 100 in quantity, we suggest placing the order directly through the website.
- We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
- We are proud to offer special discounts to medical schools, training programs, students and more.
- We offer bulk purchase discounts based on number of copies and number of titles.
Contact Us for more details
The roots of the American Thoracic Society reach back to 1905, when a small group of physicians decided that the best way to improve care for tuberculosis patients was to share their experiences and discoveries. Today, the ATS has grown into an international society with more than 15,000 members. In this introductory section, you will find information about the people and programs that make the ATS the world's leading medical association dedicated to advancing our clinical and scientific understanding of pulmonary diseases, critical illnesses and sleep-related breathing disorders.
The European Respiratory Society, or ERS, is a non-profit organization with offices in Lausanne, Brussels and Sheffield.
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
The European Respiratory Society, or ERS, is a non-profit organization with offices in Lausanne, Brussels and Sheffield.
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
Description
This resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers after consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary.
You can also find this product included in these bundles!
IDSA Guidelines Bundle
Last Updated: Oct 24, 2022
$
368.95
Print
Included Guidelines:
- Acute Hematogenous Osteomyelitis
- Antibiotic Stewardship
- Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression
- Antimicrobial Prophylaxis in Surgery
- Aspergillosis
- Asymptomatic Bacteriuria Management
- Candida
- Catheter-Associated Bacteriuria
- Chronic Kidney Disease in HIV-Infected Patients
- Chronic Pain in HIV
- Clostridium difficile
- Coccidioidomycosis
- Complicated Intra-abdominal Infection in Adults
- Cryptococcosis Management
- Diabetic Foot Infections
- Diagnosis and Treatment of Adults with Community-Acquired Pneumonia
- Drug-Susceptible Tuberculosis
- Fever and Neutropenia in Cancer Patients
- Guideline on Diagnosis and Management of Babesiosis
- Healthcare-Associated Infections A Compendium of Prevention Recommendations
- Hospital-acquired and Ventilator-Associated Pneumonia
- Infectious Diarrhea
- Influenza Update for the 2020 - 2021 Flu Season
- Leishmaniasis
- Management of Outpatient Parenteral Antimicrobial Therapy
- Methicillin-Resistant Staphylococcus aureus (MRSA)
- Native Vertebral Osteomyelitis in Adults
- Neurocysticercosis
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
- Pediatric Community-Acquired Pneumonia
- Prevention, Diagnosis and Treatment of Lyme Disease
- Primary Care Guidance for Persons with HIV
- Prosthetic Joint Infection
- Rhinosinusitis
- Skin and Soft Tissue Infections
- Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute-Care Hospitals
- Streptococcal Pharyngitis Diagnosis and Management
- Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women
- Treatment of Drug-Resistant Tuberculosis
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease
- Tuberculosis Diagnosis Adults and Children
- Vaccination of the Immunocompromised Host
- Ventriculitis and Meningitis Healthcare-Associated
ATS Guidelines Bundle
Last Updated: May 9, 2022
$
300.95
Print
Included Guidelines:
- Definition, Evaluation and Treatment of Severe Asthma
- Diagnosis and Detection of Sarcoidosis
- Diagnosis and Treatment of Adults with Community-Acquired Pneumonia
- Diagnosis of Hypersensitivity Pneumonitis in Adults
- Diagnosis of Idiopathic Pulmonary Fibrosis
- Diagnosis of Primary Ciliary Dyskinesia
- Diagnosis, Risk Stratification, And Management Of Pulmonary Hypertension Of Sickle Cell Disease.
- Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing
- Drug-Susceptible Tuberculosis
- Ethical and Policy Considerations in Organ Donation after Circulatory Determination of Death
- Evaluation and Management of Obesity Hypoventilation Syndrome
- Exercise-induced Bronchoconstriction
- Fractional Exhaled Nitric Oxide for Asthma
- Home Oxygen Therapy for Adults with Chronic Lung Disease
- Home Oxygen Therapy for Children
- Hospital-acquired and Ventilator-Associated Pneumonia
- Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in Adults
- Initiating Pharmacologic Treatment in Tobacco-Dependent Adults
- Liberation from Mechanical Ventilation in Critically Ill Adults
- Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease
- Management of Malignant Pleural Effusions
- Managing Conscientious Objections in Intensive Care Medicine
- Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome
- Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice
- Noninvasive Ventilation For Acute Respiratory Failure
- Nucleic Acid-Based Testing for Non-Influenza Viral Pathogens
- Pediatric Chronic Home Invasive Ventilation
- Pharmacologic Management of Chronic Obstructive Pulmonary Disease
- Post-Prematurity Respiratory Disease
- Prevention and Management of COPD Exacerbations
- Requests for Potentially Inappropriate Treatments In Intensive Care Units
- Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea
- Routine Lung Function Tests
- Severe Asthma Management
- Sleep Apnea, Sleepiness, and Driving Risk in Noncommercial Drivers
- Treatment of Drug-Resistant Tuberculosis
- Treatment Of Idiopathic Pulmonary Fibrosis
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease
- Tuberculosis Diagnosis Adults and Children
Related Guidelines
Tuberculosis Diagnosis Adults and Children
Last Updated: Apr 17, 2017
Healthcare-Associated Infections A Compendium of Prevention Recommendations
Last Updated: Jan 5, 2015
Enteral Nutrition in Preterm Infants
Last Updated: Oct 4, 2020
Candida
Last Updated: Feb 4, 2016
Clostridium difficile
Last Updated: Oct 22, 2014
Duration of Contact Precautions in Acute Care Settings
Last Updated: Mar 22, 2018
NICU Staphylococcus aureus
Last Updated: Dec 16, 2020
Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing
Last Updated: Nov 3, 2016
Drug Allergy
Last Updated: Feb 16, 2023